Navigation Links
Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference
Date:1/4/2012

WORCESTER, Mass. and TORONTO, Jan. 4, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT) announced today that representatives of the Company's wholly-owned subsidiary, Antigen Express, Inc., will be in attendance at the 2012 JPMorgan Healthcare Conference in San Francisco from January 8 through 13.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b )

Representatives of Antigen Express will be available over the course of the conference to meet with prospective partners, collaborators, and investors in respect of the Antigen Express proprietary platform immunotherapeutic vaccine technologies.

Mark Fletcher, Generex President & Chief Executive Officer, has commented:  "In particular, the recently announced positive interim clinical data from our Phase 2b study in HER-2 expressing breast cancer subjects makes the time ripe for discussions with prospective partners and collaborations in respect of a Phase 3 study of the breast cancer vaccine."

Interested parties are invited to contact:

Mr. Joseph Moscato
Seahawk Capital Partners, Inc.
646-599-6222
jmoscato@seahawkcap.com

About AE37 and Ii-Key Hybrid Platform Technology

Antigen Express is a platform technology and product-based company developing proprietary vaccine formulations for large, unmet medical needs.  The Company's Ii-Key Hybrid technology platform entails the modification of fragments of antigens to increase their potency in stimulating critical members of the immune response, known as CD4+ T helper cells.  Incorporating the Ii-Key modification along with tumor-associated antigens can greatly enhance the immune system's ability to recognize and destroy cancer cells bearing any of the targeted antigens as well as increasing immunological memory.

The first product
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 The National Association of Specialty ... its 6 th Annual Most Influential in ... of Ear Professionals International Corporation (dba EPIC Hearing ... the nation, EPIC Hearing Service Plans cover millions ... organizations, employers, health plans, unions and through partnerships ...
(Date:5/5/2015)...  Stryker Orthopaedics announced today its return to THE ...  Since becoming the "Official Joint Replacement Products of ... ago, the company has made 14 stops along the ... activation the Stryker Mobility Zone – a destination designed ... health. Proving to be a successful program, Stryker has ...
(Date:5/5/2015)... 2015  Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy ... has unanimously elected Co-founder, President, Chief Executive Officer and ... role of Chairman of the Board. Mr. Tussing replaces ... from the Board and his role as Chairman and ... pursue his candidacy for the President of ...
Breaking Medicine Technology:EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 3Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 2Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 3
... Accuray Incorporated, a global leader in the field of ... to address the unique technical, business and operational needs ... a means for sites to receive upgrades and technology ... program, named Diamond Plus, continues to push the innovative ...
... Oct. 29 Echo Therapeutics, Inc. (OTC Bulletin Board: ... Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous ... transdermal drug delivery, today announced that Patrick T. Mooney, ... Echo Therapeutics will present at the LifeTech Capital 1st ...
Cached Medicine Technology:Accuray Announces Expanded Service Program 2Accuray Announces Expanded Service Program 3Accuray Announces Expanded Service Program 4Echo Therapeutics to Present at the LifeTech Capital 1st Annual Miami Medical Investors Conference 2
(Date:5/5/2015)... (PRWEB) May 05, 2015 May is National ... the Institute for Better Bone Health . Founded by ... aims to educate both consumers and physicians about the latest ... of bone health. , According to a study recently published ... total Americans are affected by osteoporosis and low bone mass. ...
(Date:5/5/2015)... May 05, 2015 Care ... guidebook called “Medicare Breakeven Challenges? A Model ... includes:, ,     Formulas for two ... measuring but should be ,     A ... “white space” and ensures sustained efficient operations ...
(Date:5/5/2015)... After conducting a nationwide executive search ... West Holt Medical Services in Atkinson, Neb., ... skilled healthcare executive with more than 10 years of ... June 1st. , “Brad brings a proven track record ... and success in building strong relationships with physicians,” said ...
(Date:5/5/2015)... McMunn Associates , a leader in ... today that it has officially launched a new web ... president and founder, Larry McMunn, the new web site ... for growth and expansion for the next several decades. ... years by building close, personal relationships with clients. McMunn ...
(Date:5/5/2015)... 2015 Swiftwick, a leading athletic performance ... a presenting sponsor. The partnership launched May 3, 2015, ... The COLORDASH is an innovative, untimed community race where ... by the COLORDASH. At each kilometer of the race, ... “let the color move them.” , The organization demonstrates ...
Breaking Medicine News(10 mins):Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2Health News:Swiftwick Partners with COLORDASH as Presenting Sponsor 2
... in mice pinpoints role of gene mutation in triggering ... Scientists believe they may have found the biological trigger ... In the March 12 issue of Neuron ... increased levels of the neurotransmitter glutamate in the brain ...
... 11 The Coalition for Ethical Imaging (CEI), a ... practices in Texas, has announced its support for Senate ... companion bill in the House, House Bill 2599 by ... imaging patient care and safety in the state of ...
... a leading provider of the flu shot across the nation, has ... ... (Vocus) March 11, 2009-- Nationwide Medical/Surgical, a leading provider of ... a preservative-free flu vaccine ., , ,The influenza virus, more ...
... Calif., March 11 MAP Pharmaceuticals, Inc. (Nasdaq: ... the Cowen and Company 29th Annual Health Care Conference on ... MA.A live webcast of the presentation will be available on ... http://www.mappharma.com . A replay will also be available within 24 ...
... have pinpointed a cellular pathway that determines whether ... their development. When this pathway, known as PI3K ... and proliferate independent of the amount of food ... tumors respond to dietary restrictiondefined as food consumption ...
... changing needs of Philadelphia seniorsPHILADELPHIA, March 11 ... senior care services, NewCourtland has announced plans to ... homes to AristaCare Health Services. The transaction will ... living options and community-based programming for seniors. AristaCare ...
Cached Medicine News:Health News:Clues Found to Brain Mechanism Behind Migraines 2Health News:The Coalition for Ethical Imaging Announces Support for Diagnostic Imaging Bills Introduced in Texas Legislature 2Health News:The Coalition for Ethical Imaging Announces Support for Diagnostic Imaging Bills Introduced in Texas Legislature 3Health News:Nationwide Medical/Surgical Announces Preservative Free Flu Vaccine Available 2Health News:Cell pathway on overdrive prevents cancer response to dietary restriction 2Health News:Cell pathway on overdrive prevents cancer response to dietary restriction 3Health News:NewCourtland Network Plans to Transfer Ownership of Five Nursing Homes 2
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: